Write in a clean editor, then format for Journal of Allergy and Clinical Immunology Global in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Allergy and Clinical Immunology Global is a peer-reviewed journal published by Elsevier, covering Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research, Allergic Rhinitis and Sensitization.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Allergy and Clinical Immunology Global 12 (2023) 45–58.
Formats any DOI in Journal of Allergy and Clinical Immunology Global style. No sign-up. |
| Publishes research in | Asthma and respiratory diseases Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Drug-Induced Adverse Reactions Dermatology and Skin Diseases |
| ISSN | 2772-8293 |
| Citation impact (2-yr) | 1.79 |
| h-index | 19 |
| i10-index | 61 |
| Total citations | 2,354 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | National Institute of Allergy and Infectious Diseases |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Background: Food allergy is common and causes substantial morbidity and even mortality. Safe and effective treatments for food allergy would therefore be highly desirable, especially for individuals with multiple food allergies. Objectives: Our aim was to describe a phase 3 study on treatment of patients with multiple food allergies with omalizumab. Methods: The study was…
Background: Telazorlimab is a humanized anti-OX40 monoclonal antibody being studied for treatment of T-cell-mediated diseases. Objective: This randomized, placebo-controlled, phase 2b dose-range finding study investigated efficacy, safety, pharmacokinetics, and immunogenicity of telazorlimab in subjects with atopic dermatitis. Methods: In this 2-part study (NCT03568162), adults (≥18 years) with moderate-to-severe disease were randomized to various regimens of…
BackgroundReinforcement of the immune-regulatory pathway is a feasible strategy for prevention and therapy of allergic asthma. The short-chain fatty acids (SCFAs) acetate, propionate, and butyrate are pleiotropic microbial fermentation products known to induce regulatory T (Treg) cells and exert an immune-regulatory effect. The cellular mechanism underlying SCFA immune regulation in asthma is not fully understood.ObjectiveWe…
Background: Hereditary angioedema (HAE) is a potentially life-threatening disorder characterized by recurrent episodes of subcutaneous or submucosal swelling. HAE with normal C1 inhibitor (HAE-nC1-INH) is an underdiagnosed condition. Although the association with genetic variants has been identified for some families, the genetic causes in many patients with HAE-nC1-INH remain unknown. The role of genes associated…
Background: Allergenic proteins can cause IgE-mediated adverse reactions in sensitized individuals. Although the sequences of many allergenic proteins have been identified, bioinformatics data analysis with advanced computational methods and modeling is needed to identify the basis for IgE binding and cross-reactivity. Objective: We aim to present the features and use of the updated Structural Database…
